COX-1 and 2, intestinal integrity, and pathogenesis of nonsteroidal anti-inflammatory drug enteropathy in mice
- 1 June 2002
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 122 (7) , 1913-1923
- https://doi.org/10.1053/gast.2002.33647
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid ArthritisNew England Journal of Medicine, 2000
- Comparison of the effect of rofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis: A randomized, double-blind, placebo-controlled trialArthritis & Rheumatism, 2000
- Aspirin for cancerNature Medicine, 1999
- Anti-inflammatory and Upper Gastrointestinal Effects of Celecoxib in Rheumatoid ArthritisJAMA, 1999
- Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysisProceedings of the National Academy of Sciences, 1999
- Gastrointestinal Toxicity of Nonsteroidal Antiinflammatory DrugsNew England Journal of Medicine, 1999
- Specific inhibition of cyclooxygenase‐2 with MK‐0966 is associated with less gastroduodenal damage than either aspirin or ibuprofenAlimentary Pharmacology & Therapeutics, 1999
- Nonsteroidal anti-inflammatory drugs and gastroenteropathy: The second hundred yearsGastroenterology, 1997
- Towards a better aspirinNature, 1994
- Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humansGastroenterology, 1993